Serum Elabela expression is decreased in hypertensive patients and could be associated with the progression of hypertensive renal damage
Abstract Background Elabela, a recently discovered hormonal peptide containing 32 amino acids, is a ligand for the apelin receptor. It can lower blood pressure and attenuate renal fibrosis. However, the clinicopathological relationship between Elabela level and renal damage caused by benign hyperten...
Main Authors: | Geng Tian, Qian Zheng, Qingru Zhang, Xiaoyu Liu, Xuehong Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-024-01674-1 |
Similar Items
-
Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study
by: Zheng Ma, et al.
Published: (2021-08-01) -
Advances in the study of ELABELA in renal physiological functions and related diseases
by: YuRong Liu, et al.
Published: (2023-10-01) -
Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
by: Zheng Ma, et al.
Published: (2021-03-01) -
Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: A preliminary study
by: Yutao Li, et al.
Published: (2020-04-01) -
Maternal plasma Elabela levels in intrauterine growth restriction
by: Filiz Alkan Baylan, et al.
Published: (2021-12-01)